예측 유전자 검사 및 소비자 유전체학 시장 규모, 점유율, 성장 분석 : 검사 유형별, 기술별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Predictive Genetic Testing And Consumer Genomics Market size was valued at USD 7.4 Billion in 2024 and is poised to grow from USD 8.44 Billion in 2025 to USD 24.06 Billion by 2033, growing at a CAGR of 14.0% during the forecast period (2026-2033).

The market for predictive genetic testing and consumer genomics is primarily driven by technological advancements that reduce sequencing costs and enhance bioinformatics tools. This sector encompasses various services, including clinical predictive testing, ancestry reports, pharmacogenomics, and prenatal diagnostics directly available to consumers. Its significance lies in shaping disease prevention, treatment strategies, and drug development. The evolution of testing methods, from microarrays to whole genome sequencing, exemplified by companies like 23andMe, reflects increasing sophistication. A crucial factor for market growth is the generation of actionable evidence, which fosters clinician and payer acceptance. When genomic tests demonstrate the ability to predict tumor treatments and improve survival rates, hospitals are likely to integrate these tests into clinical practices, driving higher market demand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Predictive Genetic Testing And Consumer Genomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Predictive Genetic Testing And Consumer Genomics Market Segments Analysis

Global predictive genetic testing and consumer genomics market is segmented by test type, technology, end-user and region. Based on test type, the market is segmented into Predictive Genetic Testing and Consumer Genomics. Based on technology, the market is segmented into Next-Generation Sequencing, Polymerase Chain Reaction, Microarray Analysis and Others. Based on end-user, the market is segmented into Direct-to-Consumer, Healthcare Providers and Research Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Predictive Genetic Testing And Consumer Genomics Market

One key market driver for the global predictive genetic testing and consumer genomics market is the increasing demand for personalized medicine. As healthcare moves towards a more tailored approach, individuals are seeking genetic insights that can inform their health decisions, risk assessments, and preventive measures. Advances in genomic technologies, coupled with a growing awareness of the importance of genetics in understanding health, are propelling consumers to actively engage with genetic testing services. This shift not only empowers individuals with knowledge about their genetic predispositions but also fosters a surge in research and development, enhancing the overall landscape of predictive genetic testing.

Restraints in the Global Predictive Genetic Testing And Consumer Genomics Market

One significant market restraint for the global predictive genetic testing and consumer genomics market is the ethical and privacy concerns surrounding genetic data. Consumers are increasingly apprehensive about how their genetic information may be used or misused, particularly regarding potential discrimination by employers or insurers. Additionally, regulatory challenges and varying laws related to genetic data protection can hinder companies' ability to provide services confidently. The complex nature of genetic information may also deter individuals from participating in testing, as they may struggle to understand the implications of their results, ultimately limiting the market's growth potential.

Market Trends of the Global Predictive Genetic Testing And Consumer Genomics Market

The Global Predictive Genetic Testing and Consumer Genomics market is experiencing a significant upward trend driven by the rising demand for personalized healthcare solutions. This shift is largely fueled by consumers seeking proactive approaches to health management that leverage genetic insights. As healthcare providers and consumer genomics firms collaborate, they are developing innovative screening protocols and tailored lifestyle interventions that transform genetic data into actionable health plans. The emphasis on preventive healthcare, coupled with advancements in genetic counseling and integration into routine medical practices, is empowering individuals to better manage their health risks, thus shaping a more informed and engaged consumer base in the healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Predictive Genetic Testing And Consumer Genomics Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Predictive Genetic Testing
  • Hereditary Cancer Screening
  • Cardiovascular Risk Screening
• Consumer Genomics
  • Ancestry Testing
  • Diet Fitness Personalization

Global Predictive Genetic Testing And Consumer Genomics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Next-Generation Sequencing
• Polymerase Chain Reaction
• Microarray Analysis
• Others

Global Predictive Genetic Testing And Consumer Genomics Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Direct-to-Consumer
• Healthcare Providers
• Research Laboratories

Global Predictive Genetic Testing And Consumer Genomics Market Size & CAGR (2026-2033)

• North America (Test Type, Technology, End-User)
  • US
  • Canada
• Europe (Test Type, Technology, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Technology, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Technology, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Technology, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sonic Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invitae
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guardant Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations